𝔖 Bobbio Scriptorium
✦   LIBER   ✦

M1963 Gene Therapy of Pancreatic Cancer Targeting the K-RAS Oncogene

✍ Scribed by Lisiansky, Victoria; Kazanov, Diana; Naumov, Inna; Shapira, Shiran; Kraus, Sarah; Arber, Nadir

Book ID
123541177
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
50 KB
Volume
138
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interferon-Ξ± and antisense K-ras RNA com
Interferon-Ξ± and antisense K-ras RNA combination gene therapy against pancreatic cancer
✍ Kazuteru Hatanaka; Koichi Suzuki; Yoshiaki Miura; Kimiko Yoshida; Shumpei Ohnami πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

## Abstract Interferon alpha (IFN‐α) is used worldwide for the treatment of a variety of cancers. For pancreatic cancer, recent clinical trials using IFN‐α in combination with standard chemotherapeutic drugs showed some antitumor activity of the cytokine, but the effect was not significant enough t

Comparative analysis of mutations in the
Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer
✍ Georgina Berrozpe; James Schaeffer; Miguel Angel Peinado; Francisco X. Real; Man πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 827 KB

Mutations in codon I 2 of K-ras occur in a high proportion of pancreatic cancer cases. Although there is evidence that p53 mutations also occur in this tumor, few studies have been reported to date and no comparison has been made of K-ras and p53 mutations in the same tissues. Single-strand conforma